½ÃÀ庸°í¼­
»óǰÄÚµå
1618264

¼¼°èÀÇ Á·Çϼö Ä¡·á Àåºñ ½ÃÀå : ÀλçÀÌÆ®¡¤°æÀï ȯ°æ¡¤½ÃÀå ¿¹Ãø(-2030³â)

Foot Drop Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DelveInsight | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á·Çϼö Ä¡·á Àåºñ ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È CAGR 8.15%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á·Çϼö Ä¡·á Àåºñ ½ÃÀåÀº ´Ù¹ß¼º °æÈ­ÁõÀ» Æ÷ÇÔÇÑ ¸¸¼º ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, ´Ù¸® ÅëÁõÀÇ Áõ·Ê ¼ö Áõ°¡, ³ë·É Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ »ó´çÇÑ ½ÃÀå ¼ºÀåÀ» º¸¿©ÁÝ´Ï´Ù.

Á·Çϼö ¹ß Ä¡·á Àåºñ: ½ÃÀå ¿ªÇÐ

WHO µ¥ÀÌÅÍ(2023) ¿¡ µû¸£¸é, ¼¼°è¿¡¼­ 180¸¸¸í ÀÌ»óÀÌ ´Ù¹ß¼º °æÈ­ÁõÀ» ¾Î°í ÀÖ´Ù°í º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¼º°æÈ­ÁõÀº ¸é¿ª°è°¡ ½Ç¼ö·Î ³ú³ª ô¼ö¸¦ °ø°ÝÇÏ´Â °ÍÀ¸·Î ¹ßº´ÇÕ´Ï´Ù. Á¾Á¾ Á·Çϼö¸¦ Æ÷ÇÔÇÑ ¿îµ¿ Àå¾Ö¸¦ À¯¹ßÇϱ⠶§¹®¿¡ ´Ù¹ß¼º °æÈ­Áõ Áõ°¡´Â Á·Çϼö Ä¡·á Àåºñ ¼ö¿ä¸¦ Å©°Ô °ßÀÎÇÕ´Ï´Ù. ±â´ÉÀû Àü±â ÀÚ±Ø Àåºñ¿Í °°Àº °í±Þ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù.

WHO°¡ 2021³â¿¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2015³âºÎÅÍ 2050³â »çÀÌ¿¡ Àüµµ »ç°íÀÇ 60¼¼ ÀÌ»ó ºñÀ²Àº 12%¿¡¼­ 22%·Î µÎ¹è·Î ´Ã¾úÀ¸¸ç, 2050³â¿¡´Â Àü ¼¼°è 21¾ï ¸í¿¡ ´ÞÇÑ´Ù°í º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ 2030³â¿¡´Â 6¸í¿¡ 1¸íÀÌ 60¼¼ ÀÌ»óÀÇ ³ëÀÎ ¼¼°è Àα¸ÀÇ °í·ÉÈ­´Â ³úÁ¹Áß, ¸»ÃÊ ½Å°æ Àå¾Ö, º¯¼º Áúȯ°ú °°Àº ³ëÈ­ °ü·Ã ÁúȯÀÇ À¯º´·üÀ» Áõ°¡½Ãŵ´Ï´Ù. ³ëÀÎÀÇ ¿îµ¿ ´É·ÂÀ» ³ôÀÌ°í »îÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇÑ Ä¡·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î Àü±â ÀÚ±Ø ÀåºñÀÇ ºÎ¼­´Â 2023³â¿¡ Å« ¼öÀÍ Á¡À¯À²À» º¸¿©ÁÝ´Ï´Ù.

ÀÌ Àåºñ´Â ÷´Ü ±â´ÉÀû Àü±â ÀÚ±Ø ±â¼úÀ» »ç¿ëÇÏ¿© ôÃß ±ÙÀ°À» Ȱ¼ºÈ­ÇÏ°í °È±â¸¦ °³¼±ÇÏ¿© Àüº¹ À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¶ÇÇÑ ³úÁ¹ÁßÀ̳ª ´Ù¹ß¼º °æÈ­Áõ µîÀÇ ½Å°æÁúȯ¿¡ ´ëÇÑ ÀçȰ¿¡ÀÇ ÀÀ¿ëÀ̳ª Ä¡·áÈ¿°ú¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ÀÌ Á¦Ç°ÀÇ º¸±ÞÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è Á·Çϼö Ä¡·á Àåºñ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ¹ý ±ÔÁ¦ ȯ°æ, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ±¸ºÐ, Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀå º¸°í¼­ : ¼Ò°³

  • Á¶»ç ¹üÀ§
  • ½ÃÀå ºÐ·ù
  • ½ÃÀåÀÇ »óÁ¤

Á¦2Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦3Àå °æÀï ±¸µµ

Á¦4Àå ±ÔÁ¦ ºÐ¼®

  • ¹Ì±¹
  • À¯·´
  • ÀϺ»
  • Áß±¹

Á¦5Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀå : ÁÖ¿ä ¿äÀÎ ºÐ¼®

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ½Å°æ ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • ÇÏÁöÀÇ ÅëÁõ Áõ°¡
    • °í·ÉÈ­ Àα¸ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
    • Àå±â »ç¿ë¿¡ µû¸¥ ºÎÀÛ¿ë
    • ÇÇÆÃ °ü·Ã ¹®Á¦
  • ½ÃÀå ±âȸ
    • °³ÀÎÈ­µÈ ¿þ¾î·¯ºí ¼Ö·ç¼Ç °³¹ß

Á¦6Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀå : Porter's Five Forces ºÐ¼®

Á¦7Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀåÀÇ Æò°¡

  • Á¦Ç° À¯Çüº°
    • Àü±âÀÚ±ØÀåºñ
    • Àåºñ/ºÎ¸ñ
  • ¿ëµµº°
    • ½Å°æÀå¾Ö
    • ±ÙÀ°Àå¾Ö
    • ³ú¿Í ô¼öÀÇ Áúȯ
    • ±âŸ
  • Áö¿ªº°
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±âŸ Áö¿ª

Á¦8Àå Á·Çϼö Ä¡·á Àåºñ ½ÃÀå : ±â¾÷ ¹× Á¦Ç° ÇÁ·ÎÆÄÀÏ

  • Ottobock
  • Bioness Inc
  • AxioBionics
  • Saebo, Inc.
  • OrthoPediatrics Corp.
  • Turbomed Orthotics
  • Ossur
  • Thrive Orthopedics
  • Allard USA Inc.
  • NextStep Robotics
  • Arthrex, Inc.
  • Evolution Devices
  • Narang Medical Limited
  • AliMed
  • Cionic

Á¦9Àå KOLÀÇ °ßÇØ

Á¦10Àå ÇÁ·ÎÁ§Æ® Á¢±Ù¹ý

Á¦11Àå DelveInsight Á¤º¸

Á¦12Àå ¸éÃ¥»çÇ× ¹× ¹®ÀÇ

JHS 25.01.09

Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic neurological disorders and the growing cases of lower limb pain worldwide

The foot drop treatment devices market is projected to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.

Foot Drop Treatment Devices Market Dynamics:

As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis. It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and the spinal cord. The prevalence of multiple sclerosis significantly drives the demand for foot drop treatment devices, as multiple sclerosis often leads to motor impairments, including foot drop. The condition disrupts mobility and independence, requiring advanced solutions like functional electrical stimulators to restore gait.

As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging global population increases the prevalence of age-related conditions like stroke, peripheral neuropathy, and degenerative disorders, which are major causes of foot drop. This drives the demand for treatment devices to enhance mobility and improve the quality of life in elderly individuals.

Therefore, all the factors stated above collectively will drive the overall foot drop treatment devices market growth.

However, the side effects associated with prolonged usage, fitting-related issues, and others may prove to be challenging factors for the foot drop treatment devices market growth during the forecast period.

Foot Drop Treatment Devices Market Segment Analysis:

Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the foot drop treatment devices, the electrical stimulator category is expected to have a significant revenue share in the year 2023. This is due to their non-invasive nature, ability to restore functional movement, and effectiveness in re-educating muscles.

These devices use advanced functional electrical stimulation technology to activate dorsiflexor muscles, improving gait and reducing the risk of falls. Their portability, customization options, and compatibility with wearable designs make them convenient for daily use. Additionally, the increasing awareness about their therapeutic benefits and their application in rehabilitation for neurological conditions like stroke and multiple sclerosis is further expected to drive their adoption.

Therefore, the widespread uses and key features of electrical stimulators that enhance their performance are solidifying the impact on the growth of the overall foot drop treatment devices market, during the forecast period from 2024 to 2030.

North America is expected to dominate the overall foot drop treatment devices market:

Among all the regions, North America is expected to dominate the foot drop treatment devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.

According to data from the Centers of Disease Control and Prevention (2023), it was stated that guillain-barre syndrome is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. In the United States, an estimated 3,000 to 6,000 people develop guillain-barre syndrome each year. Thus the rising cases of guillain-barre syndrome is increasing demand for foot drop treatment devices as guillain-barre syndrome often causes nerve damage leading to muscle weakness and foot drop.

Further, the Centre for Disease Control and Prevention (2021), stated that the percentage of adults experiencing lower limb pain rose with age, starting at 21.0% for individuals aged 18-29, increasing to 28.8% for those aged 30-44, 43.4% for adults aged 45-64, and reaching 50.3% for those aged 65 and over. The increasing prevalence of lower limb pain with age is driving the demand for foot drop treatment devices. As more individuals experience knee issues or age-related pain, the likelihood of developing foot drop increases, creating a larger patient base for assistive devices to improve mobility and quality of life.

Additionally, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional foot drop treatment devices market growth. The presence of key players with their strong distribution networks ensures widespread availability and accessibility of these devices across the region, thus increasing their revenue shares in the market, along with supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American foot drop treatment devices market.

Foot Drop Treatment Devices Market key players:

Some of the key market players operating in the foot drop treatment devices market include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.

Recent Developmental Activities in the Foot Drop Treatment Devices Market:

  • In March 2022, Cionic, a company committed to improving the lives of people with mobility differences by helping them move more independently through bionic clothing, announced the FDA clearance for its lightweight leg-worn Cionic Neural Sleeve(TM), a functional electrical stimulation to assist in gait for people with foot drop and leg muscle weakness.
  • In September 2021, Evolution Devices announced the launch of its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis. EvoWalk remote therapy platform allows foot drop patients to meet with physical therapists (PTs) virtually, providing them with a personalized and comprehensive rehab program to help them improve their mobility.

Key Takeaways from the Foot Drop Treatment Devices Market Report Study

  • Market size analysis for current foot drop treatment devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the foot drop treatment devices market.
  • Various opportunities available for the other competitors in the foot drop treatment devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current foot drop treatment devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for foot drop treatment devices market growth in the coming future?

Target Audience who can be benefited from this Foot Drop Treatment Devices Market Report Study

  • Foot drop treatment devices product providers
  • Research organizations and consulting companies
  • Foot drop treatment devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in foot drop treatment devices
  • Various end-users who want to know more about the foot drop treatment devices market and the latest technological developments in the foot drop treatment devices market.

Frequently Asked Questions for the Foot Drop Treatment Devices Market:

1. What are foot drop treatment devices?

  • A foot drop treatment device is a medical device designed to assist individuals with foot drop, a condition characterized by difficulty in lifting the front part of the foot due to weakness or paralysis of the dorsiflexor muscles.

2. What is the market for foot drop treatment devices?

  • The foot drop treatment devices market is projected to grow at a rate of 8.15% CAGR during the forecast period forecast period from 2024 to 2030.

3. What are the drivers for the foot drop treatment devices market?

  • The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the foot drop treatment devices market?

  • Some of the key market players operating in foot drop treatment devices include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.

5. Which region has the highest share in the foot drop treatment devices market?

  • North America is expected to dominate the overall Foot Drop Treatment Devices market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Foot Drop Treatment Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Foot Drop Treatment Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Foot Drop Treatment Devices Market Key Factors Analysis

  • 5.1. Foot Drop Treatment Devices Market Drivers
    • 5.1.1. Rising prevalence of chronic neurological disorders
    • 5.1.2. Growing cases of lower limb pain
    • 5.1.3. Rising geriatric population
  • 5.2. Foot Drop Treatment Devices Market Restraints and Challenges
    • 5.2.1. Side effects associated with prolonged usage
    • 5.2.2. Fitting-related issues
  • 5.3. Foot Drop Treatment Devices Market Opportunities
    • 5.3.1. Development of personalized wearable solutions

6. Foot Drop Treatment Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Foot Drop Treatment Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Electrical Stimulator
    • 7.1.2. Braces/Splints
  • 7.2. By Application
    • 7.2.1. Neuropathy
    • 7.2.2. Muscle Disorders
    • 7.2.3. Brain & Spinal Disorders
    • 7.2.4. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.3.3. India Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Foot Drop Treatment Devices Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Foot Drop Treatment Devices Market Size in USD million (2021-2030)

8. Foot Drop Treatment Devices Market Company and Product Profiles

  • 8.1. Ottobock
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Bioness Inc
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. AxioBionics
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Saebo, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. OrthoPediatrics Corp.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Turbomed Orthotics
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Ossur
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Thrive Orthopedics
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Allard USA Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. NextStep Robotics
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Arthrex, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Evolution Devices
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Narang Medical Limited
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. AliMed
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Cionic
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦